BUDAPEST (Reuters) - Hungarian drug maker Richter and its partner Actavis on Tuesday said a Phase III trial had positive results in anti-psychotic drug Cariprazine's effects to prevent relapse for schizophrenia patients.
via Reuters: Health News Read More Here..
No comments:
Post a Comment